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ABSTRACT
The primary cilium is a microtubule-based sensory
organelle. The molecular mechanism that regulates cil-
iary dynamics remains elusive. Here, we report an
unexpected finding that MLN4924, a small molecule
inhibitor of NEDD8-activating enzyme (NAE), blocks
primary ciliary formation by inhibiting synthesis/
assembly and promoting disassembly. This is mainly
mediated by MLN4924-induced phosphorylation of AKT1
at Ser473 under serum-starved, ciliary-promoting con-
ditions. Indeed, pharmaceutical inhibition (by MK2206)
or genetic depletion (via siRNA) of AKT1 rescues
MLN4924 effect, indicating its causal role. Interestingly,
pAKT1-Ser473 activity regulates both ciliary synthesis/
assembly and disassembly in a MLN4924 dependent
manner, whereas pAKT-Thr308 determines the ciliary
length in MLN4924-independent but VHL-dependent
manner. Finally, MLN4924 inhibits mouse hair regrowth,
a process requires ciliogenesis. Collectively, our study
demonstrates an unexpected role of a neddylation inhi-
bitor in regulation of ciliogenesis via AKT1, and pro-
vides a proof-of-concept for potential utility of MLN4924
in the treatment of human diseases associated with
abnormal ciliogenesis.
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INTRODUCTION
The primary cilium (immotile cilium), a microtubule-based
organelle, that projects from the apical surface of most
eukaryotic cells, has emerged as a key organelle involved in
many physiological and developmental processes (Goetz
and Anderson, 2010). The primary cilium acts like a cellular
‘antenna’ to sense and respond to the extracellular envi-
ronment (Ishikawa and Marshall, 2011). Defects in ciliogen-
esis or ciliary function are responsible for many human
ciliopathies, commonly sharing the pathological combina-
tions of kidney cyst, mental retardation, retinal degeneration,
polydactyly, diabetes and obesity (Singla and Reiter, 2006;
Eggenschwiler and Anderson, 2007). Potential involvement
of abnormal primary cilia in tumorigenesis was also impli-
cated, as evidenced by reduced or loss of primary cilia in
human cancer cell lines derived from breast carcinoma,
melanoma, clear cell renal cell carcinoma (Liu et al., 2018).
However, whether ciliary dysfunction is a cause or a con-
sequence of tumorigenesis remains elusive.
Neddylation modification is a process of covalent
attachment of NEDD8, a ubiquitin-like peptide, to a lysine
residue of a given protein substrate, catalyzed by NEDD8-
activating enzyme (NAE, E1), NEDD8-conjugating enzyme
(E2), and NEDD8 ligase (E3) (Zhao et al., 2014). MLN4924,
also known as pevonedistat, is a specific small molecule
inhibitor of NAE (Soucy et al., 2009), currently in clinical trials
for the treatment of cancer (Nawrocki et al., 2012; Zhou
et al., 2018). MLN4924 binds to NAE to form a covalent
NEDD8-MLN4924 adduct that cannot be further utilized in
subsequent intraenzyme reactions, thus blocking the entire
neddylation modification (Brownell et al., 2010). Extensive
preclinical studies have shown that MLN4924 induces
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growth arrest, apoptosis, senescence and autophagy in a
variety of human cancer cell lines both in vitro cell culture
setting and in vivo xenograft models (Zhao et al., 2014; Zhou
et al., 2018). MLN4924 also showed to block angiogenesis
and sensitize cancer cells to chemo- and radiation therapies
(Zhou et al., 2018). Whether and how MLN4924 regulates
cilium formation is completely unknown.
AKT, also known as protein kinase B (PKB), is a family of
pleckstrin homology PH domain containing serine threonine
kinases with three members AKT1, AKT2, and AKT3,
encoded by paralogous genes. Three members are closely
related, but functionally distinct (Wang et al., 2017). AKT1/
PKB is activated in a phosphoinositide 3-kinase (PI3K)-de-
pendent manner (Sarbassov et al., 2005). Full activation of
AKT/PKB requires the phosphorylation at both Thr308 and
Ser473. Phosphoinositide-dependent kinase 1 (PDK1) is
responsible for the phosphorylation at Thr308, whereas
phosphorylation at Ser473 is fulfilled by PDK2 which
includes mTOR complex 2 (mTORC2) and integrin-linked
kinase (ILK) (Persad et al., 2001). The PI3K/AKT axis is one
of the most important intracellular signaling pathways that
regulates many important biological processes including
proliferation, autophagy, apoptosis and differentiation, and its
deregulation is actively involved in many human diseases,
including cancer (Persad et al., 2001; Fresno Vara et al.,
2004; Zhang et al., 2012). However, potential involvement of
PI3K/AKT in ciliogenesis is much less studied. One study
showed that inhibition of AKT1/2 suppressed both ciliogen-
esis and cilia length (Suizu et al., 2016), whereas another
study, in contrast, reported that increased PI3K/AKT signal-
ing promoted cilia loss without determining the effect on cilia
length (Conduit et al., 2017). Thus, whether and how AKT1
and its family members regulate ciliogenesis remain elusive.
The VHL (von Hippel-Lindau) tumor-suppressor gene is
responsible for an autosomal-dominant inherited tumor
syndrome that manifests as hemangioblastomas of the
retina and central nervous system combined with renal clear
cell carcinoma and pheochromocytoma (Richards, 2001).
The best characterized function of pVHL (the product of VHL
gene) is to act as a substrate recognition component of
Cullin-2 E3 ligase for targeted ubiquitylation and degradation
of HIF-1α (hypoxia inducible factor-1α) in an oxygen-de-
pendent manner (Kaelin, 2008). In addition, pVHL interacts
with many other proteins to regulate a variety of biological
processes, including microtubule dynamics, cell prolifera-
tions, extracellular matrix deposition and primary cilia main-
tenance (Frew and Krek, 2007). While it was reported that
pVHL positively regulates primary cilia through both HIF-1-
dependent and -independent mechanisms (Kuehn et al.,
2007), its potential involvement in the regulation of cilio-
genesis by neddylation is previously unknown.
In the present study, we showed that MLN4924, a small
molecule inhibitor of protein neddylation, significantly sup-
pressed cilia assembly and promoted cilia disassembly.
Mechanistically, the MLN4924 effect appears to be mediated
by activation of pAKT-Ser473 and can be blocked by AKT1
inhibitor or siRNA-based AKT1 silencing. Furthermore, we
found that pAKT-Thr308 appear to negatively regulates cilia
length in a VHL-dependent, but MLN-4924 independent
manner. Finally, we found that hair regrowth, a process
dependent of primary cilia can be inhibited by MLN4924.
Collectively, our study provides the proof-of-concept evi-
dence that MLN4924 may have utility in the treatment of
human diseases associated with abnormal cilia outgrowth
seen in some types of cancer, such as adenocarcinoma of
the lung and colon, follicular lymphoma and a subtype of
medulloblastoma (Han et al., 2009; Yasar et al., 2017).
RESULTS
MLN4924 blocks ciliogenesis by inhibiting initiation
and promoting disassembly
Previous studies have shown that ubiquitylation regulates
cilia assembly and disassembly (Hossain and Tsang, 2018),
and several ciliary-associated proteins such as CP110
(D’Angiolella et al., 2010) Aurora A (Kwon et al., 2012) are
substrates of Cullin-RING ligases (CRLs), suggesting that
CRL may regulate ciliogenesis. To pursue this, we used
MLN4924, a small molecule that specifically inhibits NAE to
block the entire neddylation process, thus indirectly inhibiting
ligase activity of CRLs, which requires cullin neddylation
cFigure 1. MLN4924 blocks ciliogenesis by inhibiting
initiation and promoting disassembly. (A–C). Effect of
MLN4924 on cilia initiation: BEAS2B cells were treated
with DMSO or MLN4924 (0.3 μmol/L) at the beginning of
serum starvation for indicated periods of time (A, top
panel), followed by immunofluorescence staining with
anti-Arl13b and γ-tubulin (γ-tub) antibodies, and photog-
raphy (A, bottom panel). Percentage of ciliated cells
were counted (B) or cilia length measured (C), and the
results plotted. Shown is mean ± SEM from three
independent experiments. **P < 0.01, ***P <
0.001. (D–F) Effect of MLN4924 on cilia disassembly:
BEAS2B cells were treated with MLN4924 (0.3 μmol/L)
for entire 24 h, or at 12 h post serum starvation for
indicated time periods (D, top panel), followed by
immunofluorescence and photography (D, bottom panel).
Percentage of ciliated cells were counted (E) or cilia
length measured (F), and the results plotted. Shown is
mean ± SEM from three independent experiments. **P <
0.01. (G–I) UBA3 knockdown significantly inhibits cilia
formation: BEAS2B cells were transfected with scram-
bled control siRNA or siUBA3 under serum starved
condition for indicated periods of time, followed by
western blotting with indicated Ab (G) or immunofluo-
resence staining of cilia and photography (H). Percent-
age of ciliated cells were counted (I), and the results
plotted. Shown is mean ± SEM from three independent
experiments. **P < 0.01.
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(Deshaies, 1999). Cilia assembly was initiated in immortal-
ized human bronchial epithelium BEAS2B cells by serum
starvation. Arl13b and acetylated tubulin (Ac-tub) were used
as the markers for primary cilia, whereas γ-tubulin was used
as the marker for centrioles (Fig. S1A). MLN4924 treatment,
along with the DMSO control, was conducted at the begin-
ning of serum starvation for various time periods up to 12 h
(Fig. 1A, top panel). In DMSO control group, percentage of
ciliated cells increased, as starvation period prolonged.
MLN4924 treatment caused a significant inhibition of cilia
initiation, starting at 6 h and extended up to 12 h (Fig. 1A and
1B). However, MLN4924 had no effect on the cilia length
(Fig. 1C). Similar results were observed in human retinal
pigment epithelial (RPE1) cells (Fig. S1B and S1C). We
confirmed that the concentration used for MLN4924
(0.3 μmol/L) effectively blocked cullin neddylation within 1 h
of treatment (Fig. S1D and S1E), was not cytotoxic (20-fold
less than IC50) (Fig. S1F), and with no obvious effect on cells
population stayed at the G0/G1 phase (Fig. S1G).
We next determined potential effect of MLN4924 on cilia
disassembly. In a window of 24 h post serum starvation, cells
were treated with MLN4924 for entire 24 h, or at 12 h post
serum starvation, when cilia were formed, for various time
periods (from 1 to 12 h), (Fig. 1D, top panel). A time-de-
pendent reduction in percentage of ciliated cells were
observed which were statistically significant in all time points
tested, indicating that MLN4924 also effectively accelerated
cilia disassembly (Fig. 1D and 1E). Again, MLN4924 had no
effect on cilia length and cell population at the G0/G1 phase
(Fig. S1H). The similar results were observed in IMCD3
cells, a murine inner medullary collecting duct line (Fig. S1I
and S1J). Finally, we used genetic approach via siRNA-
based silencing of Uba3/NAEβ, the catalytic subunit of NAE
to which MLN4924 binds (Brownell et al., 2010), and showed
that Uba3/NAEβ depletion significantly inhibits cilia formation
(Fig. 1G–I). Collectively, these results clearly demonstrated
that neddylation inhibitor MLN4924 suppresses cilia forma-
tion by inhibiting assembly and promoting disassembly, and
this process is independent of cell cycle arrest at the G0/G1
phase.
AKT activation plays a causal role in MLN4924-induced
suppression of cilia initiation
To elucidate the mechanism by which MLN4924 inhibits cil-
iogenesis, we first examined potential involvement of CP110
and Cep97, two well-studied centriolar proteins which sup-
pressed cilia assembly (Spektor et al., 2007). Also CP110
was previously reported to be a substrate of SCF/CRL1cyclinF
E3 ligase (D’Angiolella et al., 2010), thus likely being sub-
jected to MLN4924 regulation. In BEAS2B cells, serum
starvation (DMSO group) increased the levels of CP110,
which is not affected by MLN4924 treatment. On the other
hand, two forms of Cep97 were detected, and serum star-
vation induced conversion of the slow-migrating form to the
fast-migrating form. Interestingly, MLN4924 blocked this
conversion to maintain Cep97 in the duplet status, although
it is unclear whether Cep97 activity is affected (Fig. S2A).
Importantly, depletion of CP110 (Fig. S2B) or Cep97
(Fig. S2C) reduced ciliated cell population, but had no effect
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on MLN4924 inhibition of cilia assembly (Fig. S2D and S2E).
Our observations that serum starvation induced CP110, and
CP110 knockdown reduced cilia assembly suggested that
CP110 acts as a promotor of ciliogenesis in BEAS2B cells. It
is worth noting that two recent studies showed that CP110
can act as either an inhibitor or a promoter of ciliogenesis
(Walentek et al., 2016; Yadav et al., 2016). It was also
reported that Aurora A was involved in the process of cilia
disassembly (Pugacheva et al., 2007). We, therefore,
determined potential effect of MLN4924 under cilia disas-
sembly condition in BEAS2B cells. MLN4924 had no effect
on the levels of total or phospho-Aurora, nor on the distri-
bution of pAurora-positive cells at centriole (Fig. S2F and
S2G). Taken together, none of common cilia regulatory
proteins, including CP110, Cep97 and Aurora A, was
involved in MLN4924 effect on cilia initiation or disassembly
under our experimental settings.
We recently showed that MLN4924 could activate AKT1
upon EGF addition to serum-starved cells via inducing epi-
dermal growth factor receptor (EGFR) dimerization (Zhou
et al., 2016), and two studies reported that EGFR inhibitor
could maintain ciliogenesis, and prevented smoke mediated
ciliary loss in airways (Khan et al., 2016; Valencia-Gattas
et al., 2016), suggesting that the EGFR/AKT1 signal may
mediate MLN4924 effect on ciliogenesis. We, therefore,
determined whether MLN4924 blockage of ciliogenesis can
be rescued by small molecule inhibitors of EGFR or AKT. In
BEAS2B cells, MLN4924 activated EGFR, whereas EGFR
inhibitor Erlotinib effectively blocked EGFR phosphorylation
and completely rescued MLN4924 inhibitory effect on cilia
formation in a cilia disassembly assay (Fig. S2H and S2I).
We next focused on AKT1, a downstream target of EGFR
signal and found that MLN4924 effectively induced AKT1
phosphorylation at Ser473 without much effect on Thr308
(Fig. 2A, compared lanes 2&3 vs. 4&5). Importantly, inacti-
vation of pAKT1-Ser473 by its inhibitor MK2206 at 1 μmol/L,
which had minor, if any, effect on pAKT1-Thr308 (Fig. 2A),
partially rescued MLN4924 inhibitory effect on cilia assembly
in time-dependent manners, while MK2206 alone had no
effect (Fig. 2B and 2C). Neither compound alone nor their
combination had any effect on ciliary length (Fig. 2D).
We further determined causal role of AKT1 via siRNA-
based knockdown (Fig. 2E), and found that AKT1 knock-
down (siAKT1) significantly stimulated cilia assembly at all-
time points tested, and rescued MLN4924 inhibitory effect at
6 h time points and thereafter (Fig. 2F and 2G). Interestingly,
siAKT1 significantly stimulated cilia growth, as evidenced by
extended ciliary length in a manner independent of
MLN4924 (Fig. 2H). Finally, we showed that compared to
siCont, siAKT1 had no effect on G0/G1 population (Fig. 2I),
excluding the possibility that siAKT1 regulated cilia assembly
through altering cell cycle progression. Collectively, it
appears that MLN4924-induced AKT1 activation via Ser473
phosphorylation is responsible at least in part for its inhibitory
effect on ciliary assembly, and AKT1 protein amount rather
than its pAKT1-Ser473 kinase activity regulates ciliary length
in a MLN4924-independent manner.
AKT1 activation also plays a causal role in MLN4924-
promoted cilia disassembly
Compared to cilia assembly, mechanistic details of cilia
disassembly are much less understood in normal or patho-
logical conditions (Cao et al., 2009; Liang et al., 2016). To
further investigate possible role of AKT1 in cilia disassembly,
we employed cilia disassembly assay condition (Fig. 1D)
and added MLN4924 or MK2206, alone or in combination
into serum-free medium after cilia formation. Again,
MLN4924 increased the levels of pAKT1-Ser473, whereas
MK2206 effectively inhibited it. On the other hand, MLN4924
or MK2206 only moderately increased or decreased the
levels of AKT1-Thr308, respectively (Fig. 3A). Although
MK2206 itself had no effect on cilia disassembly, it fully
rescued the disassembly-promoting effect of MLN4924
(Fig. 3B and 3C). Again, both drugs had no effect on cilia
length (Fig. 3D).
We further used a siRNA-based knockdown approach,
and found siAKT1 (Fig. 3E) fully rescued MLN4924 disas-
sembly-promoting effect (Fig. 3F and 3G), and again
extended cilia length in a MLN4924-independent manner
(Fig. 3H). Similar siAKT1 rescuing effect was observed in
RPE1 cells (Fig. S3A–C) without affecting the G1/G0 popu-
lation (Fig. S3D).
It was reported that RICTOR is mainly responsible for the
AKT1 phosphorylation at Ser473 (Cicenas, 2008). We,
therefore, determined potential involvement of RICTOR in
MLN4924 activation in pAKT-Ser473. We found that
MLN4924, at different incubation time or doses, did not
increase RICTOR protein levels under both cilia assembly
and disassembly conditions (Fig. S3E), and RICTOR
knockdown (siRICTOR) partially blocked MLN4924-induced
pAKT1-Ser473 activatation, but did not rescue cilia initiation-
inhibiting effect of MLN4924 (Fig. S3F&G), suggesting a
requirement for complete pAKT1-Ser473 inactivatation, as
shown in Fig. 2A–C. Taken together, it appears that
MLN4924 activated pAKT-Ser473 to block cilia initiation
or promote cilia disassembly in a RICTOR-independent
manner, whereas AKT amount is responsible for cilia length
under both assembly and disassembly conditions indepen-
dent of MLN4924.
AKT1, but not its family members, AKT2 or AKT3,
regulates ciliogenesis and disassembly
In mammalian cells, the AKT kinase family has three iso-
forms: AKT1, AKT2 and AKT3. Although being encoded by
three distinct genes, they share a high degree of identity at
amino acid levels with overall similar functions (Wang et al.,
2017). However, several studies showed that different AKT
isoforms could also execute specific functions in a manner
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dependent of cellular context and substrate specificity
(Polytarchou et al., 2011). To determine whether AKT regu-
lation on ciliogenesis is AKT1 specific, we used siRNA
knockdown approach and directly compared the effect of
three AKT isoforms on inhibitory effect of MLN4924 under
both cilia assembly and disassembly culture conditions. The
siRNA-based knockdown was effective against AKT1 and
AKT2, but less against AKT3 (Fig. 4A). While AKT1 knock-
down stimulated ciliogenesis when acting alone, and fully
rescued MLN4924 inhibitory effect in combination, knock-
down of AKT2 or AKT3, in contrast, further inhibited cilio-
genesis either acting alone or in combination with MLN4924
with more robust seen in AKT3 knockdown (Fig. 4B and 4C).
Furthermore, unlike AKT1 knockdown which prolonged cil-
iary length, knockdown of neither AKT2 nor AKT3 had any
effect (Fig. 4D).
We next determined the knockdown effect of three iso-
forms under cilia disassembly condition (Fig. 4E), and found
a rescue effect on percentage of ciliated cells and ciliary
length only by AKT1, not by AKT2 or AKT3 (Fig. 4F–H).
Collectively, among AKT family isoforms, AKT1 is only one
that specifically regulates cilia initiation and cilia growth
(judged by ciliary length) under both cilia assembly and
disassembly conditions.
We further determined potential involvement of few well-
known ciliary regulatory proteins in mediating siAKT1 effect.
While AKT2 knockdown had no effect on the levels of
CP110, Cep97 or NDE1, a centrosomal phosphoprotein and
a negative regulator of ciliary length (Kim et al., 2011),
knockdown of AKT1 or AKT3 reduced the levels of Cep97,
and interestingly, AKT1 knockdown specifically reduced
NDE1 levels (Fig. S4A–C). Given that AKT1 and AKT3 had
opposite effect on cilia initiation and growth, it is unlikely that
Cep97 would play a role in the process. We, therefore,
focused on NDE1 and determined its potential role in
mediating siAKT1 effect by a rescue experiment. Ectopic
expression of NDE1, to much higher levels than that of
endogenous one (Fig. S4D), had minor effect at earlier (6 h)
but no effect at later time points (12 h and 24 h) on cilia
initiation without affecting ciliary length, when in combination
Figure 2. continued.
Figure 2. AKT activation plays a causal role in MLN4924-
induced suppression of cilia initiation. (A–D) Effect of AKT1
activation on ciliogenesis: BEAS2B cells were cultured in
normal serum containing medium (lane 1), then switched to
serum starved condition (lanes 2–9) and treated with MLN4924
(0.3 μmol/L) or MK2206 (1 μmol/L) alone or in combination
indicated periods of time, followed by western blotting with
indicated Ab (A) or by immunofluorescence staining with anti-
Arl13b and γ-tubulin (γ-tub) antibodies, and photography (B).
Percentage of ciliated cells were counted (C) or cilia length
measured (D), and the results plotted. Shown is mean ± SEM
from three independent experiments. **P < 0.01. (E–H) Effect of
AKT1 knockdown on cilia formation: BEAS2B cells were
transfected with scrambled control siRNA or siAKT1, treated
with DMSO or MLN4924 (0.3 μmol/L) under serum starved
condition for indicated periods of time, and Western blotting with
indicated Abs (E) or immunofluoresence staining of cilia and
photography (F). Percentage of ciliated cells were counted
(G) or cilia length measured (H) and the results plotted. Shown
is mean ± SEM from three independent experiments. **P <
0.01. (I) AKT1 knockdown has no effect on the G0/G1 phase:
BEAS2B cells were transfected with scrambled control siRNA
or siAKT1, treated with DMSO or MLN4924 (0.3 μmol/L)
treatment under serum starved condition for cilia initiation,
followed by FACS analysis. Shown are percentage of cells at
the G0/G1.
b
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with AKT1 knockdown (Fig. S4E and S4F). Thus, AKT1
regulation of cilia initiation or ciliary growth/length is inde-
pendent of NDE1, or CP110 and Cep97.
AKT1 specifically regulates cilia length through pAKT1-
Thr308
Given that the main AKT1 kinase activity is mediated through
pAKT1-Thr308 (Fresno Vara et al., 2004), we then focused on
whether AKT1 effect on cilia length is mediated via pAKT1-
Thr308. We used GSK2334470 (designated as GSK470), a
highly selective PDK1 inhibitor (Najafov et al., 2011), which
inactivatedpAKT1-Thr308 asaPDK1downstreamsubstrate, as
well as pAKT1-Ser473, known to undergoes auto-phosphory-
lation in aPDK1-dependentmanner (Persad et al., 2001). Cells
were pretreated with GSK470 for 12 or 18 h prior to serum
starvation for 6 or 12 h, respectively (Fig. 5A, top panel). As
expected, GSK470 effectively inactivated AKT1 phosphoryla-
tions at both Thr308 and Ser473 sites (Fig. 5A, bottom panel).
Significantly, it promoted ciliogenesis by increasing percentage
of ciliated cell population and cilia length in a dose and time
dependent manner in BEAS2B cells (Fig. 5B–D). The similar
results were also observed in RPE1 cells (Fig. S5A–C). Given
thatpAKT1-Ser473 is involved in regulationofciliatedpopulation
only, we proposed that pAKT1-Thr308 is likely responsible for
the control of cilia length.
To further determine the role of AKT phosphorylation on
ciliogenesis, we used the gain-of-function approach.
BEAS2B cells were transfected with various plasmids
expressing wild-type AKT (HA-AKT1), two phosphorylate
mutants (HA-AKT1-308A or HA-AKT1-473A) or AKT consti-
tutively active form (HA-myr-AKT1) (Fig.5E), followed by
serum-starvation for various time points. Constitutively active
HA-myr-AKTeffectively inhibited ciliogenesis, as reflected by
reduced ciliated population and shortened cilia length. While
AKT1-473A mutant is the least effective in blocking cilio-
genesis, AKT1-308A mutant is less effective in blocking cilia
length (Fig. 5F–H). Similar results were observed in RPE1
cells (Fig. S5D–G). Taken together, our results support that
notion that pAKT1-Ser473 plays a major role in blocking cili-
ogenesis, which is MLN4924-dependent, whereas pAKT1-
Thr308 plays a major role in blocking cilia length in a
MLN4924-independent manner.
Cross-talk between AKT-1 and pVHL in regulation
of ciliogenesis
Previous studies have demonstrated that pVHL positively
regulates ciliogenesis in a number of cellular systems
(Schermer et al., 2006; Kuehn et al., 2007) and pVHL can
act either upstream or downstream of AKT1 in a cell context
dependent manner (Frew et al., 2008; Guo et al., 2016;
Castaneda et al., 2017). We, therefore, determined potential
involvement of pVHL in AKT regulation of ciliogenesis. In
both BEAS2B and RPE cells, pVHL co-transfection with
AKT1 inhibited the levels of total AKT1 as well as two active
forms of AKT1, with a greater inhibition on pAKT1-Thr308,
particularly in RPE cells (Figs. 6A and S6A), and partially
rescued AKT1-induced suppression of cilia initiation and cilia
growth (Figs. 6B–D and S6B–D). Using a loss-of-function
approach, we found that pVHL knockdown, on one hand,
inhibited ciliogenesis, and blocked the stimulatory effect of
AKT knockdown (Fig. 6E–G). On the other hand, abrogated
promoting effect of AKT knockdown, while itself having no
effect on cilia growth (Fig. 6H). Similar results on ciliogenesis
were seen in RPE1 cells (Fig. S6E–G). Taken together,
AKT1 and pVHL cross-talk with each other to precisely
regulate cilia initiation and growth.
MLN4924 inhibits hair regrowth by blocking
ciliogenesis in mouse skin
Finally, we extended our cell culture study to an in vivo
mouse model. It is well-established that hair regrowth
requires primary cilia (Lehman et al., 2009; Goetz and
Anderson, 2010; Rishikaysh et al., 2014; Abe and Tanaka,
2017). To determine in vivo consequence of MLN4924 inhi-
bition of ciliogenesis, we depilated mouse hair on dorsal
areas and divided mouse into two groups: one received the
vehicle control and the other receiving non-toxic dose (30
mg/kg) of MLN4924 via s.c. injection, 5 days per week for
two weeks (Wei et al., 2012). The hair regrowth was recor-
ded at the end of two-week treatment. As shown in Fig. 7A,
MLN4924 administration significantly inhibited hair regrowth.
The H&E staining of skin tissue sectioned from depilated
areas showed a significantly reduction of skin follicle in
MLN4924-treated skin (Fig. 7B). Reduced number of cilia
positive hair follicles was also observed in MLN4924-treated
b Figure 3. AKT activation plays a causal role in MLN4924-
promoted cilia disassembly. (A–D) Effect of AKT1 activation
on cilia disassembly: BEAS2B cells were treated with MLN4924
(0.3 μmol/L) or MK2206 (1 μmol/L) alone or in combination
under serum starved condition for cilia disassembly for indi-
cated periods of time, followed by Western blotting with
indicated Abs (A), or by immunofluorescence staining, and
photography (B). Percentage of ciliated cells were counted
(C) or cilia length measured (D), the results plotted. Shown is
mean ± SEM from three independent experiments. **P <
0.01. (E–H) Effect of AKT1 knockdown: BEAS2B cells were
transfected with scrambled control siRNA or siAKT1, then
treated with DMSO or MLN4924 (0.3 μmol/L) under cilia
disassembly condition for indicated periods of time, followed
by western blotting with indicated Ab (E) or immunofluoresence
staining of cilia and photography (F). Percentage of ciliated cells
were counted (G), cilia length measured (H), and the results
plotted. Shown is mean ± SEM from three independent
experiments. **P < 0.01, ***P < 0.001.
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group (Fig. 7C). We have repeated this experiment with
MLN4924 being applied either locally or via s.c injection and
found that suppression of cilia regrowth was only effective
via s.c. injection (Fig. S7). Taken together, our study showed
that cilia inhibitory effect MLN4924 can be extended from cell
culture setting to an in vivo mouse model.
DISCUSSION
MLN4924, also known as pevonedistat, is the first in class
small molecular inhibitor of neddylation activating enzyme,
currently at the Phase I/II clinical trial for anti-cancer appli-
cation, acting alone or in combination with other chemo-
drugs (Zhao et al., 2014; Zhou et al., 2018). In preclinical
settings, MLN4924, via blocking the entire neddylation
modification, showed numerous anti-cancer activities by
inducing growth arrest, apoptosis, autophagy, inhibiting
angiogenesis and inflammatory responses in a cell context
dependent manner (for review, see (Zhou et al., 2018)). In
this study, we made an unexpected finding that MLN4924
blocked primary ciliogenesis by inhibiting initiation and pro-
moting disassembly without affecting cilia growth or cilia
length. Importantly, this inhibition is a general event, seen in
multiple cell lines, and occurs rapidly in a manner indepen-
dent of G1/G0 arrest, a status known to promote ciliogenesis
(Ishikawa and Marshall, 2011).
It is previously unknown that neddylation modification
could directly regulate the process of ciliogenesis, although a
number of ciliary-associated proteins (e.g., CP110 and Aur-
ora A) are substrates of Cullin-RING ligases (CRLs) (D’An-
giolella et al., 2010; Hasanov et al., 2017), whose activity
required NEDD8 attachment via neddylation (Deshaies
et al., 2010). Nevertheless, the involvement of these sub-
strates was excluded in our experimental settings via siRNA
knockdown approaches. We then turned our attention to the
EGFR-AKT axis, based upon our recent finding that
MLN4924 at nanomolecular concentration, triggered EGFR
dimerization to promote stem cell characteristics under
serum starved condition (Zhou et al., 2016), a condition that
triggers ciliogenesis as well (Pugacheva et al., 2007).
Indeed, inactivation of either EGFR or AKT1 completely
abrogated the inhibitory effect of MLN on ciliogenesis, indi-
cating a causal role.
In the process of using siRNA knockdown of AKT1 to
rescue MLN4924 inhibitory effect, we made yet another
unexpected finding that knockdown of AKT1, but not its
family members AKT2 or AKT3, not only restored ciliated cell
population up to the control level, a process which is
b Figure 4. AKT1, but not its family members, AKT2 or AKT3,
regulates ciliogenesis and disassembly. (A–D) Effect of AKT
family members: BEAS2B cells were transfected with scram-
bled control siRNA, siAKT1, siAKT2 or siAKT3, then treated
with DMSO or MLN4924 (0.3 μmol/L) under cilia initiation
condition for indicated periods of time, followed by western
blotting with indicated Abs (A) or immunofluoresence staining of
cilia and photography (B). Percentage of ciliated cells were
counted (C) or cilia length measured (D), the results plotted.
Shown is mean ± SEM from three independent experiments.
**P < 0.01, ***P < 0.001. (E–H) Effect of knockdown of AKT
family members on cilia disassembly and growth: BEAS2B cells
were transfected with scrambled control siRNA, siAKT1,
siAKT2 or siAKT3, then treated with DMSO or MLN4924
(0.3 μmol/L) under cilia disassembly condition for 2 h, followed
by Western blotting with indicated Abs (E) or immunofluores-
ence staining of cilia and photography (F). Percentage of
ciliated cells were counted (G) or cilia length measured (H), the
results plotted. Shown is mean ± SEM from three independent
experiments. **P < 0.01.
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MLN4924-dependent, but also stimulated cilia growth by
extending its length in MLN4924 independent manner. The
length of cilia is precisely regulated in cells, and abnormal
cilia length correlates with several ciliopathies (Nigg and
Raff, 2009). Previous studies have shown that cilia length is
subject to regulation by several proteins, including NDE1,
F-actin, VHL, FBXW7, AKT1 (Kim et al., 2011; Dere et al.,
2015; Nikonova and Golemis, 2015; Suizu et al., 2016;
Zhang et al., 2016). We found that under our experimental
setting, cilia length is not regulated by NDE1, but by AKT1,
particularly pAKT1-Thr308 and pVHL. Two lines of evidence
support a role of pAKT1-Thr308. First, GSK2334470, a
selective inhibitor of PDK1, which blocks pAKT1-Thr308,
elongated cilia in a dose-dependent manner; Second, ecto-
pic expression of AKT1-T308A, a AKT1-Thr308 dead mutant,
inhibits cilia growth to a much lesser extent than that of wild-
type AKT1 or AKT-Ser473 (Fig. 5H). It is worth noting that a
previous study using the RPE1 or MEF cells showed that
knockdown or knockout of AKT1/2, particularly AKT2, sup-
pressed cilia development by reducing ciliated cell popula-
tion and cilia length (Suizu et al., 2016). We used human
BEAS2B cells and found that AKT2 knockdown reduced
ciliated cell population without affecting cilia length, whereas
AKT1 knockdown significantly increased ciliated population
and cilia length (Fig. 4), suggesting a cell line dependent
effect of AKT family members on cilia development. We
reason our finding by proposing that AKT1 knockdown would
suppress cell growth and survival, allowing cells to
differentiation in a way to trigger cilia development under
optimal serum starvation condition. Nevertheless, exact
underlying mechanism, by which AKT1 regulates cilia
development in a cell context dependent manner, remains
elusive, but certainly an interesting subject for future
investigation.
VHL has been widely implicated in regulation of ciliogen-
esis (Kuehn et al., 2007), which acts as either upstream or
downstream regulator of AKT1 in a cell context dependent
manner (Thoma et al., 2007; Guo et al., 2016). In our
experimental setting in both BEAS2B and RPE1 cells, ectopic
VHL co-expression inactivated AKT1 phosphorylation, par-
ticularly on pAKT1-Thr308. Functionally, VHL expression
increased ciliated cell population and promoted cilia growth, it
also fully rescued negative effect of AKT1. The pVHL
knockdown, on the other hand, reduced ciliated cell popula-
tion, but not affected cilia growth. pVHL knockdown also fully
rescued stimulating effect of siAKT1 for both cilia initiation and
cilia growth. These results clearly suggested that pVHL acts
upstream of AKT1 as a positive regulator of cilia formation
and growth. Under the condition of AKT1 knockdown, when
cilia formation and growth were stimulated, pVHL appears to
act downstream of AKT1 to mediate its effect which is abro-
gated by simultaneous pVHL knockdown.
Finally, we extended our cell culture-based observations
to an in vivo mouse model in which re-growth of depilated
skin hair requires primary cilia (Lehman et al., 2009; Goetz
and Anderson, 2010; Rishikaysh et al., 2014; Abe and
Tanaka, 2017). Indeed, MLN4924 treatment significantly
inhibited ciliated cell population in affected mouse skin with
reduced hair follicles, indicating effectiveness of MLN4924 in
blocking in vivo ciliogenesis. Abnormal cilia overgrowth was
observed in a number of human cancers such as adeno-
carcinoma of the lung and colon, follicular lymphoma and a
subtype of medulloblastoma (Han et al., 2009; Yasar et al.,
2017). By blocking ciliogenesis, MLN4924 may have a
unique application to treat human cancers which rely on cilia
for growth or drug resistance (Jenks et al., 2018).
In summary, our study supports a working model as fol-
lows. a) MLN4924 triggers EGFR dimerization, leading to
activation of pAKT1-Ser473 to inhibit ciliogenesis by blocking
cilia assembly and promoting cilia disassembly. b) Activation
of pAKT1-Thr308 via the PI3K-PDK1 signal inhibits cilia
growth and shortens cilia length. pVHL acts either upstream
or downstream of AKT1 to positively regulate ciliogenesis
(Fig. 7D). Our finding that AKT1 negatively regulates cilio-
genesis may have a therapeutic implication. In human dis-
eases with ciliopathies, such as polycystic kidney (4), the
selective AKT1 inhibitor may have a unique application to
promote cilia formation.
b Figure 5. pAKT-Thr
308 is responsible for cilia growth.
(A–D) Blockage of AKT1 activation promotes cilia initiation
and growth: BEAS2B cells were pretreated with GSK470
(3 μmol/L or 10 μmol/L) for 12 or 18 h prior to serum starvation
for 6 or 12 h, respectively (A, top panel), followed by Western
blotting with indicated Abs (A, bottom panel) or immunofluo-
resence staining of cilia and photography (B). Percentage of
ciliated cells were counted (C) or cilia length measured (D), the
results plotted. Shown is mean ± SEM from three independent
experiments. *P < 0.01, **P < 0.01, ***P < 0.001. (E–H) pAKT1-
Ser473 blocks cilia formation, whereas pAKT1-Thr308 blocks cilia
growth: BEAS2B cells were transfected with various plasmids
expressing wild type AKT1 (HA-AKT1), or mutants, HA-AKT1-
308A, HA-AKT1-473A or HA-myr-AKT1, followed by serum-
starvation for indicated periods of time, and Western blotting
with indicated Abs (E) or immunofluoresence staining of cilia
and photography (F). Percentage of ciliated cells were counted
(G) or cilia length measured (H), and the results plotted. Shown
is mean ± SEM from three independent experiments. *P < 0.01,
**P < 0.01, ***P < 0.001.
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MATERIALS AND METHODS
Cell lines and chemicals
BEASB, cells were purchased from ATCC. The RPE1 and IMCD3
cell lines were the gift from Dr. Qing Zhong. BEAS2B cells were
cultured in RPMI 1640 medium (Invitrogen, Carlsbad, CA). IMCD3
cells were cultured in DMEM medium (Invitrogen). RPE1 cells were
cultured in F12 medium (Invitrogen). All media were supplemented
with 10% fetal bovine serum. MLN4924 and MK2206 were pur-
chased from ApexBio (Houston, TX), GSK2334470 from Sel-
leckchem (Houston, TX). Erlotinib was a gift from Dr. Wanhong Xu.
All compounds were dissolved in dimethyl sulfoxide (DMSO) and
stored at −20 °C.
Immunofluorescence microscopy and imaging analysis
Cells were subjected to serum starvation in the absence or presence
of DMSO, or MLN4924 (0.3 μmol/L), MK (1 μmol/L), Erlotinib
(10 μmol/L) and GSK470 (3&10 μmol/L) for various periods of time.
Cilia were visualized by an indirect immunofluorenscence staining,
as previously described (Pugacheva et al., 2007). Image acquisition
was performed using a Nikon A1X60 microscope system (Nikon A1-
Ti, Tokyo, Japan), equipped with NIS-elements software (Nikon A1-
Ti). Percentage of ciliated cells and cilia length were counted and
measured. Cilia length was measured using ImageJ software (NIH).
The results were plotted in a bar graph. Shown is mean ± SEM from
three independent experiments.
Immunoblotting (IB)
Cell lysates after various treatments were prepared and subjected to
IB analysis as described (Gu et al., 2007). The sources of primary
antibodies were as follows: Cullin-1 (Santa Cruz, CA), phospho-
AKT-Ser473, phosphor-AKT-Thr308, pan-AKT, AKT1, AKT2, AKT3,
Aurora A, VHL, Phospho-Aurora A (Thr288)/Aurora B (Thr232)/
Aurora C (Thr198) (D13A11), PDK1, phospho-PDK1-Ser241 and
Rictor (53A2) (Cell Signaling, Denver, CO), γ-tubulin, α-tubulin Clone
AA13, acetylated tubulin Clone 6-11B-1, β-actin (Sigma, St. Louis,
MO), CP110, NDE1, Cep97, Arl13B (Proteintech, Wuhan, P.R.C).
UBA3 (Abcam, Shanghai, P.R.C). EGFR and phospho-EGFR-
Tyr845 were gifts from Dr. Wanhong Xu,
FACS (fluorescence-activated cell sorting) analysis
Cells post various treatments were harvested and fixed in 70%
ethanol overnight. Cells were washed twice with ice-cold phosphate
buffered saline (PBS) and then stained with propidiumiodide (PI,
20 mg/mL, Sigma) solution for 30 min in the dark. The samples were
then analyzed using a BD FACScan flow cytometer facility (Franklin
Lakes, NJ) for cell cycle distributions.
SiRNAs, plasmids and transfection
The siRNA oligoes to knockdown AKT1, AKT2, AKT3, CP110,
Cep97 or VHL were synthesized by GenePharma (Shanghai, P.R.
C). The sequences of siRNAs are as follows: AKT1: 5′-
GCGTGGTGAATACATCAAGACTT-3′; AKT2: 5′-GCGTGGTGAA-
TACATCAAGACTT-3, AKT3: 5′-TAGTCCAACTTCACAAATTGC-3;
CP110: 5′-AAGCAGCATGAGTATGCCAGT-3′; CEP97: 5′-GATGA-
GAAGTGAAATCAATTT-3′; VHL: 5′-TATCACACTGCCAGTGTA-
TACCTC-3′. The siRNA oligoes to knockdown UBA3 was
synthesized by RIBOBIO (Guangzhou, P.R.C). The sequence of si-
UBA3 is 5′-GCTTCTCTGCAAATGAAAT-3′. The plasmid expression
constructs, encoding HA-AKT1, HA-AKT1-308A, HA-AKT1-473A or
HA-myr-AKT, were gifts from Dr. Wenyi Wei. Cells were transfected
with siRNA duplexes (10 nmol/L) or plasmids using Lipofectamine
RNAiMAX or Lipofectamine 3000, respectively, according to the
manufacturer’s instructions (Life Technologies, Carlsbad, CA).
Animal studies
All animal studies were conducted in accordance with the guidelines
established by the University of Michigan Committee on Use and
Care of Animals. The C57BL/6 mice at 8 weeks of age were used.
Dorsal hair was removed by a hair removal cream, Nair, as descri-
bed (Wang et al., 2013). In the following day, mice were injected s.c.
with MLN4924 (30 mg/kg, five times per week), along with the
HPBCD vehicle control (Wei et al., 2012), for two weeks, or locally
applied with MLN4924 (0.3 μmol/L in 70% ethanol) once a day, 5
days per week for 2 weeks. Mice were then photographed and
sacrificed. The dorsal skin biospies were harvested, fixed in cold 4%
paraformaldehyde overnight and embedded in paraffin. Skin sec-
tions were stained with H&E and examined under microscope.
Immonofluorescence staining was performed with antibodies against
acetylated tubulin and γ-tubulin and counterstained with DAPI.
Statistical analysis
Data with two groups were analyzed by two-tailed Student’s t-tests,
and data with multiple groups were analyzed by one-way ANOVA,
followed by Bonferroni post hoc test using GraphPad Prism statis-
tical programs (GraphPad Prism, San Diego, CA). Results were
expressed as mean ± SEM from three independent assays. The P <
0.05 was considered statistically significant.
b Figure 6. Cross-talk between AKT1 and pVHL in regulation
of ciliogensis. (A–D) Effect of VHL on AKT level, activity, and
ciliogenesis: BEAS2B cells were transfected with vector, HA-
AKT1 or VHL alone or in combination, followed by serum
starvation for indicated time points, and Western blotting with
indicated Abs (A), or immunofluoresence staining of cilia and
photography (B). Percentage of ciliated cells were counted
(C) or cilia length measured (D), and the results plotted. Shown
is mean ± SEM from three independent experiments. **P <
0.01, ***P < 0.001. (E–H) Effect of pVHL knockdown on
ciliogenesis triggered by AKT1 knockdown: BEAS2B cells were
transfected with scrambled control siRNA, siAKT1, or siVHL
alone or in combination, followed by serum starved for 6 h, and
Western blotting with indicated Abs (E) or immunofluoresence
staining of cilia and photography (F). Percentage of ciliated cells
were counted (G) or cilia length measured (H), and the results
plotted. Shown is mean ± SEM from three independent
experiments. ***P < 0.001.
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Figure 7. MLN4924 inhibits hair regrowth by blocking ciliogenesis in mouse skin. (A) The dorsal hairs of mice were removed on
day 1. On day 2, mice were injected with MLN4924 (30 mg/kg) along with vehicle control, once a day, 5 days per week for 2 weeks.
The photo images were taken before and after 2 weeks of treatment. (B and C) Mice skin were harvested at the end of 2-week
treatment, fixed, embedded, sectioned, stained with H&E and photographed. The hair follicles were counted and result blotted (B), or
skin sections were stained with immonofluorescence using ciliary marker acetylated tubulin (red), positive cells were counted. All
scale bars are 200 µm. Shown is mean ± SEM from randomly selected 5 skin areas harvested from at least two mice. (D) The working
model. See text for details.
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